These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 35834884)

  • 1. Tall cell variant papillary thyroid carcinoma impacts disease-free survival at the 10 % cut-point on multivariate analysis.
    Samankan S; Militello L; Seo G; Everest S; O'Malley Q; Spaulding SL; Xing M; Matloob A; Beute J; Chai R; Doyle S; Urken ML; Brandwein-Weber M
    Pathol Res Pract; 2022 Aug; 236():154012. PubMed ID: 35834884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic implications of papillary thyroid carcinoma with tall-cell features.
    Ganly I; Ibrahimpasic T; Rivera M; Nixon I; Palmer F; Patel SG; Tuttle RM; Shah JP; Ghossein R
    Thyroid; 2014 Apr; 24(4):662-70. PubMed ID: 24262069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Papillary thyroid carcinoma tall cell variant.
    Ghossein R; Livolsi VA
    Thyroid; 2008 Nov; 18(11):1179-81. PubMed ID: 18925842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tall cell variant of papillary thyroid carcinoma without extrathyroid extension: biologic behavior and clinical implications.
    Ghossein RA; Leboeuf R; Patel KN; Rivera M; Katabi N; Carlson DL; Tallini G; Shaha A; Singh B; Tuttle RM
    Thyroid; 2007 Jul; 17(7):655-61. PubMed ID: 17696836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk Factors Associated With Recurrence and Death in Patients With Tall Cell Papillary Thyroid Cancer: A Single-Institution Cohort Study With Predictive Nomogram.
    Wu SS; Joshi N; Sharrett J; Rao S; Shah A; Scharpf J; Burkey B; Lamarre ED; Prendes B; Siperstein A; Shin J; Berber E; Jin J; Krishnamurthi V; Nasr C; Hong L; Buchberger DS; Woody N; Koyfman SA; Geiger JL
    JAMA Otolaryngol Head Neck Surg; 2023 Jan; 149(1):79-86. PubMed ID: 36454559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tall cell variant of papillary thyroid carcinoma: a population-based study in Iceland.
    Axelsson TA; Hrafnkelsson J; Olafsdottir EJ; Jonasson JG
    Thyroid; 2015 Feb; 25(2):216-20. PubMed ID: 25322334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of risk factors in metastatic/recurrent tall cell variant of papillary thyroid carcinoma.
    Okuyucu K; Alagoz E; Ince S; Arslan N
    Endokrynol Pol; 2017; 68(6):623-630. PubMed ID: 29022644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of tall cell variant histology on predicting relapse and changing the management of papillary thyroid carcinoma patients.
    Gunalp B; Okuyucu K; Ince S; Ayan A; Alagoz E
    Hell J Nucl Med; 2017; 20(2):122-127. PubMed ID: 28697188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tall Cell Variant of Papillary Thyroid Carcinoma: Impact of Change in WHO Definition and Molecular Analysis.
    Wong KS; Higgins SE; Marqusee E; Nehs MA; Angell T; Barletta JA
    Endocr Pathol; 2019 Mar; 30(1):43-48. PubMed ID: 30565013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tall-cell variant of papillary thyroid carcinoma: a matched-pair analysis of survival.
    Morris LG; Shaha AR; Tuttle RM; Sikora AG; Ganly I
    Thyroid; 2010 Feb; 20(2):153-8. PubMed ID: 20151822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the clinicopathological features and oncologic outcomes of the classic papillary thyroid carcinoma with tall cell features and tall cell variant.
    Kim K; Jung CK; Lim DJ; Bae JS; Kim JS
    Gland Surg; 2022 Jan; 11(1):56-66. PubMed ID: 35242669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liquid-based cytology improves preoperative diagnostic accuracy of the tall cell variant of papillary thyroid carcinoma.
    Lee SH; Jung CK; Bae JS; Jung SL; Choi YJ; Kang CS
    Diagn Cytopathol; 2014 Jan; 42(1):11-7. PubMed ID: 23754825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic Significance of the Proportion of Tall Cell Components in Papillary Thyroid Carcinoma.
    Ito Y; Hirokawa M; Miyauchi A; Higashiyama T; Kihara M; Miya A
    World J Surg; 2017 Mar; 41(3):742-747. PubMed ID: 27807709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Do aggressive variants of papillary thyroid carcinoma have worse clinical outcome than classic papillary thyroid carcinoma?
    Song E; Jeon MJ; Oh HS; Han M; Lee YM; Kim TY; Chung KW; Kim WB; Shong YK; Song DE; Kim WG
    Eur J Endocrinol; 2018 Sep; 179(3):135-142. PubMed ID: 29875289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Higher incidence of tall cell variant of papillary thyroid carcinoma in Graves' Disease.
    Boutzios G; Vasileiadis I; Zapanti E; Charitoudis G; Karakostas E; Ieromonachou P; Karatzas T
    Thyroid; 2014 Feb; 24(2):347-54. PubMed ID: 23786233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aggressive variants of papillary thyroid cancer: incidence, characteristics and predictors of survival among 43,738 patients.
    Kazaure HS; Roman SA; Sosa JA
    Ann Surg Oncol; 2012 Jun; 19(6):1874-80. PubMed ID: 22065195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Papillary thyroid carcinoma tall cell variant shares accumulation of mitochondria, mitochondrial DNA mutations, and loss of oxidative phosphorylation complex I integrity with oncocytic tumors.
    Tsybrovskyy O; De Luise M; de Biase D; Caporali L; Fiorini C; Gasparre G; Carelli V; Hackl D; Imamovic L; Haim S; Sobrinho-Simões M; Tallini G
    J Pathol Clin Res; 2022 Mar; 8(2):155-168. PubMed ID: 34792302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathologic features and prognostic factors of tall cell variant of papillary thyroid carcinoma: comparison with classic variant of papillary thyroid carcinoma.
    Okuyucu K; Alagoz E; Arslan N; Emer O; Ince S; Deveci S; Ayan A; Taslipinar A; Gunalp B; Azal O
    Nucl Med Commun; 2015 Oct; 36(10):1021-5. PubMed ID: 26225942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Limitations of fine-needle aspiration and core needle biopsies in the diagnosis of tall cell variant of papillary thyroid carcinoma.
    Ahn J; Jin M; Kim WG; Kim TY; Kim WB; Shong YK; Baek JH; Song DE; Jeon MJ
    Clin Endocrinol (Oxf); 2023 Jan; 98(1):110-116. PubMed ID: 35394662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is There a Difference Between Minimal and Gross Extension into the Strap Muscles for the Risk of Recurrence in Papillary Thyroid Carcinomas?
    Danilovic DLS; Castroneves LA; Suemoto CK; Elias LO; Soares IC; Camargo RY; Correa FA; Hoff AO; Marui S
    Thyroid; 2020 Jul; 30(7):1008-1016. PubMed ID: 32059626
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.